| Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity R Ross, IJ Neeland, S Yamashita, I Shai, J Seidell, P Magni, RD Santos, ... Nature Reviews Endocrinology 16 (3), 177-189, 2020 | 1513 | 2020 |
| Association of LDL cholesterol, non–HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis SM Boekholdt, BJ Arsenault, S Mora, TR Pedersen, JC LaRosa, PJ Nestel, ... Jama 307 (12), 1302-1309, 2012 | 1042 | 2012 |
| Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement IJ Neeland, R Ross, JP Després, Y Matsuzawa, S Yamashita, I Shai, ... The lancet Diabetes & endocrinology 7 (9), 715-725, 2019 | 1023 | 2019 |
| Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials SM Boekholdt, GK Hovingh, S Mora, BJ Arsenault, P Amarenco, ... Journal of the American College of Cardiology 64 (5), 485-494, 2014 | 844 | 2014 |
| Lipoprotein (a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement F Kronenberg, S Mora, ESG Stroes, BA Ference, BJ Arsenault, L Berglund, ... European heart journal 43 (39), 3925-3946, 2022 | 666 | 2022 |
| Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials DD Waters, JE Ho, DA DeMicco, A Breazna, BJ Arsenault, CC Wun, ... Journal of the American College of Cardiology 57 (14), 1535-1545, 2011 | 492 | 2011 |
| Precision nutrition: a review of personalized nutritional approaches for the prevention and management of metabolic syndrome J de Toro-Martín, BJ Arsenault, JP Després, MC Vohl Nutrients 9 (8), 913, 2017 | 460 | 2017 |
| Oxidized phospholipids, lipoprotein (a), and progression of calcific aortic valve stenosis R Capoulade, KL Chan, C Yeang, P Mathieu, Y Bossé, JG Dumesnil, ... Journal of the American College of Cardiology 66 (11), 1236-1246, 2015 | 428 | 2015 |
| Beyond low-density lipoprotein cholesterol: respective contributions of non–high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density … BJ Arsenault, JS Rana, ESG Stroes, JP Després, PK Shah, JJP Kastelein, ... Journal of the American College of Cardiology 55 (1), 35-41, 2009 | 405 | 2009 |
| Lipoprotein (a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case–control cohort BJ Arsenault, SM Boekholdt, MP Dubé, É Rhéaume, NJ Wareham, ... Circulation: Cardiovascular Genetics 7 (3), 304-310, 2014 | 320 | 2014 |
| High-density lipoprotein particle size and concentration and coronary risk K El Harchaoui, BJ Arsenault, R Franssen, JP Després, GK Hovingh, ... Annals of internal medicine 150 (2), 84-93, 2009 | 305 | 2009 |
| Lipoprotein (a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis KH Zheng, S Tsimikas, T Pawade, J Kroon, WSA Jenkins, MK Doris, ... Journal of the American College of Cardiology 73 (17), 2150-2162, 2019 | 291 | 2019 |
| Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins I Postmus, S Trompet, HA Deshmukh, MR Barnes, X Li, HR Warren, ... Nature communications 5 (1), 5068, 2014 | 287 | 2014 |
| Lipid parameters for measuring risk of cardiovascular disease BJ Arsenault, SM Boekholdt, JJP Kastelein Nature Reviews Cardiology 8 (4), 197-206, 2011 | 285 | 2011 |
| Autotaxin derived from lipoprotein (a) and valve interstitial cells promotes inflammation and mineralization of the aortic valve R Bouchareb, A Mahmut, MJ Nsaibia, MC Boulanger, A Dahou, JL Lépine, ... Circulation 132 (8), 677-690, 2015 | 260 | 2015 |
| The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study BJ Arsenault, I Lemieux, JP Després, NJ Wareham, JJP Kastelein, ... Cmaj 182 (13), 1427-1432, 2010 | 255 | 2010 |
| Levels and changes of HDL cholesterol and apolipoprotein AI in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis SM Boekholdt, BJ Arsenault, GK Hovingh, S Mora, TR Pedersen, ... Circulation 128 (14), 1504-1512, 2013 | 245 | 2013 |
| Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis D Mohty, P Pibarot, JP Després, C Côté, B Arsenault, A Cartier, P Cosnay, ... Arteriosclerosis, thrombosis, and vascular biology 28 (1), 187-193, 2008 | 238 | 2008 |
| Determinants of residual risk in secondary prevention patients treated with high-versus low-dose statin therapy: the Treating to New Targets (TNT) study S Mora, NK Wenger, DA DeMicco, A Breazna, SM Boekholdt, ... Circulation 125 (16), 1979-1987, 2012 | 211 | 2012 |
| Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with … V Di Marzo, M Cote, I Matias, I Lemieux, BJ Arsenault, A Cartier, ... Diabetologia 52, 213-217, 2009 | 207 | 2009 |
